title: Acute generalized exanthematous pustulosis induced by sorafenib.
authors.affiliation: Department of Dermatology, School of Medicine, University Clinic of Navarra, Pamplona, Spain.
authors.forename: Maider
authors.initials: M
authors.lastname: Pretel
authors.affiliation: Department of Dermatology, School of Medicine, University Clinic of Navarra, Pamplona, Spain.
authors.forename: Mercedes
authors.initials: M
authors.lastname: Iñarrairaegui
authors.affiliation: Department of Dermatology, School of Medicine, University Clinic of Navarra, Pamplona, Spain.
authors.forename: José Miguel
authors.initials: JM
authors.lastname: Lera
authors.affiliation: Department of Dermatology, School of Medicine, University Clinic of Navarra, Pamplona, Spain.
authors.forename: Leyre
authors.initials: L
authors.lastname: Aguado
authors.affiliation: Department of Pathology, School of Medicine, University Clinic of Navarra, Pamplona, Spain.
authors.forename: Miguel Angel
authors.initials: MA
authors.lastname: Idoate
mesh_terms: D056150:Acute Generalized Exanthematous Pustulosis / Q000209:etiology*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009536:Niacinamide / Q000009:adverse effects / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000009:adverse effects*; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib